NONOF Stock Overview - The Average Joe

Newsletter

Latest Issues Subscribe

Company

About Us Jobs
PNK:NONOF

Loading...

Market cap

$Loading...

Sector

Loading...

Dividend Yield

Loading...

52-week range

Loading... Loading...

Expected earnings date

August 7, 2024

Description

Loading...

Returns 1M 6M 1Y 5Y 10Y
$NONOF N/A N/A N/A N/A N/A
S&P500 N/A N/A N/A N/A N/A
Valuation P/E Ratio (TTM) P/S Ratio (TTM)
Novo Nordisk A/S Loading... Loading...
Sector Name Loading... N/A

Related

NUVLNuvalent, Inc.2.0%
DICEDICE Therapeutics, Inc.0.1%
ACLXArcellx, Inc.1.5%
PCVXVaxcyte, Inc.1.0%
VRDNViridian Therapeutics, Inc.6.0%

Analyst Ratings

Buy Loading...
Hold Loading...
Sell Loading...

Financial Overview

FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023
Revenue88,806M107,927M111,780M111,696M111,831M122,021M126,946M140,800M176,954M232,261M
Growth Rate-21.5%3.6%-0.1%0.1%9.1%4.0%10.9%25.7%31.3%
EBITDA38,094M52,488M51,616M52,164M51,164M57,791M60,215M67,556M82,040M112,940M
EBITDA Margin42.9%48.6%46.2%46.7%45.8%47.4%47.4%48.0%46.4%48.6%
Net Income26,481M34,860M37,925M38,130M38,628M38,951M42,138M47,757M55,525M83,683M
NI Margin29.8%32.3%33.9%34.1%34.5%31.9%33.2%33.9%31.4%36.0%
×

Become a better investor with our free daily newsletters

Join 250,000+ investors discovering new market trends and ideas.